• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
2-(1,8-Naphthyridin-2-yl)phenol

2-(1,8-Naphthyridin-2-yl)phenol

Product ID N0163
Cas No. 65182-56-1
Purity ≥98%
Product Unit SizeCostQuantityStock
100 mg $92.00 In stock
500 mg $222.90 In stock
1 g $371.80 In stock
5 g $1,549.80 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

This naphthalene exhibits anticancer activity; in fibrosarcoma and breast cancer cells, it increases expression of STAT1 and IFN regulatory factor 1 and enhances the ability of IFNγ to inhibit cell proliferation.

Product Info

Cas No.

65182-56-1

Purity

≥98%

Formula

C14H10N2O

Formula Wt.

222.24

IUPAC Name

6-(1H-1,8-naphthyridin-2-ylidene)cyclohexa-2,4-dien-1-one

Synonym

2-NP

Solubility

Ethanol (7 mg/mL), DMSO (50 mg/mL)

Appearance

Red Crystals

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

N0163 MSDS PDF

Info Sheet

N0163 Info Sheet PDF

References

Lynch RA, Etchin J, Battle TE, et al. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells. Cancer Res. 2007 Feb 1;67(3):1254-61. PMID: 17283162.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G4484

    Glucagon-like Peptide II, rat

    Endogenous peptide hormone, involved in intesti...

    ≥95%
  • G4480

    Glucagon, human

    Endogenous peptide hormone, counteracts insulin...

    ≥95%
  • O486179

    Omeprazole Impurity C

    Impurity of omeprazole

    ≥99%
  • V3252

    Vinorelbine Ditartrate

    Semi-synthetic vinca alkaloid from Catharanthus...

    ≥98%
  • C0377

    Catharanthine Sulfate

    Alkaloid found in Catharanthus, precursor in sy...

    ≥98%
  • O9201

    Oxaliplatin

    Pt-based DNA cross-linker.

    ≥98%
  • C0145

    Calcitriol

    Active form of vitamin D, regulates dietary Ca2...

    ≥97%
  • T0097

    10-Deacetyltaxol B

    Diterpene found in Taxus; potential microtubule...

    ≥98%
  • M1650

    Melanotan II

    Synthetis peptide, melanocortin analog; MCR ago...

    ≥98%
  • A6826

    L-Arginine Hydrochloride

    Endogenous amino acid, also found in meat, dair...

    ≥98%
  • H9712

    (E)-4-Hydroxytamoxifen

    SERM.

    ≥97%
  • R3249

    Rimantadine Hydrochloride

    Viral M2 proton channel blocker.

    ≥98%
  • S4244

    SKLB 610

    VEGFR2, PDGFR, FGFR2 inhibitor.

    ≥98%
  • A5281

    Angiotensin II (4-8), human

    Endogenous peptide fragment, involved in vasoco...

    ≥95%
  • C1629

    Cefoperazone Acid

    β-lactam cephalosporin; penicillin binding pro...

    ≥98%
  • E4416

    Eledoisin

    Peptide, substance P analog; NK agonist.

    ≥95%
  • B4248

    BKM120

    PI3K inhibitor, microtubule polymerization inhi...

    ≥98%
  • C9808

    CZC-54252

    LRRK2 inhibitor.

    ≥98%
  • N7604

    Naltriben

    δ2OR antagonist.

    ≥95%
  • T342710

    Tirzepatide

    GLP-1/GIP receptor co-agonist

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only